BRAWN BIOTECH LTD. has announced a board meeting on August 13, 2026, where the financial results for the quarter ended June 30, 2026, were approved.

For this quarter, the company reported a total income from operations of ₹6.22 Cr.

Net profit after tax stood at ₹0.15 Cr.

Earnings per share (basic and diluted) were ₹0.52. This update provides key insights into the company's recent financial performance for shareholders.